King’s College London Spinout Secures £17 Million to Scale AI Powered Hyperspectral Surgical Imaging

Hypervision Surgical secures Series A funding to deploy its FDA-cleared hyperspectral system, providing surgeons with real-time tissue insights at the pixel level.

By: AXL Media

Published: Apr 30, 2026, 8:44 AM EDT

Source: Information for this report was sourced from EurekAlert!

Capital Infusion for Next Generation Surgical Intelligence

Hypervision Surgical, a medical technology pioneer originating from King’s College London, has announced the successful closure of a £17 million Series A financing round. The investment was led by Heal Capital, with significant participation from Angelini Ventures, IP Group, and Daycrest, alongside strategic backing from Macmillan Cancer Support and SAGES Ingenuity. This capital influx is earmarked for the commercial expansion of the company’s proprietary HYPERSNAP system, which has already achieved regulatory clearance from the US Food and Drug Administration and certification within the United Kingdom.

Breaking the Visual Ceiling of Conventional Surgery

Traditional surgical procedures, even those assisted by robotic or digital systems, have historically relied on the subjective visual assessment of the surgeon. Hypervision’s Hyperspectral Intelligence platform addresses this limitation by analyzing light matter interactions across various wavelengths to reveal critical data regarding tissue health and composition. According to Christian Lautner, Founding Managing Partner at Heal Capital, while conventional cameras capture how tissue looks, this hyperspectral approach delivers quantitative insights into what is happening beneath the surface at a pixel level, establishing a new foundational layer for safer surgical outcomes.

Strategic Integration of Spectral Sensing and Cloud AI

The core of Hypervision’s technology lies in its Hyperspectral Intelligence platform, which merges proprietary on-chip spectral sensing with patented artificial intelligence analytics. This architecture is designed to be cloud scalable, transforming standard surgical imaging into a data driven decision support tool. By delivering objective information on tissue physiology during an operation, the system provides surgeons with previously inaccessible insights. CEO and Co-Founder Dr. Michael Ebner notes that this combination of advanced sensing and AI analytics represents a major milestone in the mission to build an intelligence layer that powers modern operating rooms.